Pharmafile Logo
Pharmafocus logo
Advanced Search

Oasmia

Showing 1 posts of 1 posts found.

Oasmia acquires rights to cancer drug candidate Cantrixil in $44m deal

March 1, 2021
Sales and Marketing Cancer, Kazia, Oasmia

Oasmia Pharmaceutical, an innovation-focused specialty pharmaceutical company, is set to acquire exclusive global development rights for Kazia Therapeutics’ ovarian cancer …

News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026